Compare BRAI & LMRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BRAI | LMRI |
|---|---|---|
| Founded | N/A | 2018 |
| Country | Australia | United States |
| Employees | N/A | 4335 |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | N/A | N/A |
| Metric | BRAI | LMRI |
|---|---|---|
| Price | $6.91 | $11.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $20.75 |
| AVG Volume (30 Days) | 174.2K | ★ 708.0K |
| Earning Date | N/A | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.35 |
| Revenue Next Year | N/A | $5.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.15 | $6.45 |
| 52 Week High | $32.32 | $19.45 |
| Indicator | BRAI | LMRI |
|---|---|---|
| Relative Strength Index (RSI) | 48.74 | 53.49 |
| Support Level | $6.72 | $9.97 |
| Resistance Level | $11.57 | $16.38 |
| Average True Range (ATR) | 1.03 | 0.86 |
| MACD | 0.17 | 0.00 |
| Stochastic Oscillator | 27.72 | 47.59 |
Braiin Ltd is an Australian technology company leveraging proprietary intellectual property and patented artificial intelligence/machine learning (AI/ML) technologies to deliver actionable insights across the verticals: Agriculture, Property Technology, and Customer Experience as a Service (CXaaS). The company's platforms are designed to address inefficiencies and drive data-backed decision-making across traditionally analog sectors. It prominently focuses on the agriculture technology sector, where it has successfully deployed its AI-powered solutions across multiple implementations. It provides end-to-end solutions to improve farming productivity using IoTs, Wireless Connectivity, Robotics, Software and AI/ML.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.